Table 2 Summary of complete remission and early death rates per age groups.

From: Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

Outcome endpoint

Age group

18–24 years (n = 137)

25–29 years (n = 99)

30–34 years (n = 157)

35–39 years (n = 168)

40–44 years (n = 238)

45–49 years (n = 248)

50–54 years (n = 315)

55–59 years (n = 307)

60–64 years (n = 318)

65–69 years (n = 325)

70–74 years (n = 254)

75 +  years (n = 190)

CR rate

78%

79%

75%

82%

78%

70%

72%

65%

64%

57%

47%

41%

ED rate

3%

2%

1%

2%

5%

6%

7%

8%

7%

14%

19%

24%

  1. CR complete remission, ED early death.
Back to article page